Univar Solutions and Novozymes® Provide Biological Solutions that Address Growing Health-Consciousness and Sustainability Demand in the Food Market
- Indexes close up more than 1% as investors assess Fed news
- Nike (NKE) Stock Falls On a Revenue Miss and Slashed FY Sales Outlook, Analysts Bullish Despite NT Supply Chain Challenges
- China Tells Local Authorities to Prepare For a 'Possible Storm' and Prevent Unrest as Evergrande Crisis Unravels - WSJ
- Salesforce (CRM) Raises FY22 Revenue Guidance; Initiates FY23 Revenue
- Oil prices rise, hit 2-month highs on supply worries
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
The expansion builds on the companies' recently announced partnership in the United States and Canada.
DOWNERS GROVE, Ill. and RALEIGH, N.C., April 26, 2021 /PRNewswire/ -- Univar Solutions Inc. (NYSE: UNVR) ("Univar Solutions" or "the Company"), a global chemical and ingredient distributor and provider of value-added services, and Novozymes, the world leader in biological solutions, today announced a new agreement to expand the partnership into the United States and Canadian food ingredients markets. The new food ingredients agreement takes effect May 1, one month after the companies announced an exclusive agreement expanding the partnership into the United States and Canadian beverage production, homecare, and industrial cleaning markets.
Working together in the bakery, dairy, animal protein, and plant-based food and beverage markets reinforces a strong shared commitment to provide customers with a leading, innovative food ingredient portfolio that includes enzymes and microbial process aids, helping them meet consumer demands for healthy, affordable, and sustainable food and beverage products. Novozymes' enzymes and probiotics/microbes work in a broad range of applications. They are designed to help improve product performance and offer potential options for bringing more sustainable, higher-quality products to market. Examples include helping to extend freshness properties, expediting production, boosting nutritional value, or addressing challenges in new markets such as plant-based foods and beverages.
"Univar Solutions partners with Novozymes across the globe, and we are excited to expand our collaboration in the United States and Canada to bring even more high-performing and sustainable offerings to the market," said Nick Powell, SVP, president, Specialty Chemicals and Ingredients for Univar Solutions. "We are confident our customers will benefit from our consistent focus on delivering high-quality, innovative and sustainable ingredients, backed by our strong local technical and commercial support efforts. Biological solutions are transforming the food and beverage sectors, and we look forward to leveraging our unmatched knowledge of global and regional market dynamics to help customers formulate industry-leading, sustainable ingredient solutions."
Using next-generation biological solutions in place of traditional chemicals can help customers in food ingredient sectors get more out of their raw materials and stay one step ahead of evolving food and beverage trends. In recent years, biological solutions have helped food producers deliver on key consumer trends like oat milk, for which Novozymes offers an innovative, full support package known as the Novozymes Oat 360 toolbox that helps develop oat drinks and bring them to market faster. Biological solutions are also used to support the development of other plant-based dairy products, while enabling manufacturers to make certain nutrition and health claims, such as less sugar added as well as clean-label, free-from, and sustainability product claims.
"We are excited to elevate the recently announced partnership in the United States and Canada by also including the food ingredients markets – further expanding across multiple regions and industries Univar Solutions' and Novozymes' successful collaboration for over 15 years," said Arnaud Melin, Novozymes' vice president of Consumer Biosolutions, Americas. "Observing specifically the fragmented food and beverage space, we look forward to leveraging Univar Solutions' strong commercial reach while, from an agile and scalable approach, also collaborating digitally to unlock new growth areas to reach an even broader range of customers – where Novozymes' pioneering biological solutions provide major benefits for the end consumer."
About Univar SolutionsUnivar Solutions (NYSE: UNVR) is a leading global specialty chemical and ingredient distributor representing a premier portfolio from the world's leading producers. With the industry's largest private transportation fleet and North American sales force, unparalleled logistics know-how, deep market and regulatory knowledge, world-class formulation and recipe development, and leading digital tools the company is well-positioned to offer tailored solutions and value-added services to a wide range of markets, industries, and applications. Univar Solutions is committed to helping customers and suppliers innovate and grow together. Learn more at www.univarsolutions.com.
About NovozymesNovozymes is the world leader in biological solutions. Together with customers, partners and the global community, Novozymes improves industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bio-innovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com.
NASDAQ OMX: NZYM-B • 6,500 employees • DKK 14,5 billion turnover • 30+ industries • 700+ products
Forward-Looking StatementsThis press release includes certain statements relating to future events and our intentions, beliefs, expectations, and predictions for the future, which are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond the Company's control. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the expectations and assumptions. A detailed discussion of these factors and uncertainties is contained in the Company's filings with the Securities and Exchange Commission. Potential factors that could affect such forward-looking statements include, among others: the ultimate geographic spread of the COVID-19 pandemic; the duration and severity of the COVID-19 pandemic; actions that may be taken by governmental authorities to address or otherwise mitigate the impact of the COVID-19 pandemic; the potential negative impacts of COVID-19 on the global economy and our customers and suppliers; the overall impact of the COVID-19 pandemic on our business, results of operations and financial condition; other fluctuations in general economic conditions, particularly in industrial production and the demands of our customers; significant changes in the business strategies of producers or in the operations of our customers; increased competitive pressures, including as a result of competitor consolidation; significant changes in the pricing, demand and availability of chemicals; our levels of indebtedness, the restrictions imposed by our debt instruments, and our ability to obtain additional financing when needed; the broad spectrum of laws and regulations that we are subject to, including extensive environmental, health and safety laws and regulations; an inability to integrate the business and systems of companies we acquire, including of Nexeo Solutions, Inc., or to realize the anticipated benefits of such acquisitions; potential business disruptions and security breaches, including cybersecurity incidents; an inability to generate sufficient working capital; increases in transportation and fuel costs and changes in our relationship with third party providers; accidents, safety failures, environmental damage, product quality and liability issues and recalls; major or systemic delivery failures involving our distribution network or the products we carry; operational risks for which we may not be adequately insured; ongoing litigation and other legal and regulatory risks; challenges associated with international operations; exposure to interest rate and currency fluctuations; potential impairment of goodwill; liabilities associated with acquisitions, ventures and strategic investments; negative developments affecting our pension plans and multi-employer pensions; labor disruptions associated with the unionized portion of our workforce; and the other factors described in the Company's filings with the Securities and Exchange Commission. We caution you that the forward-looking information presented in this press release is not a guarantee of future events or results, and that actual events or results may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "plan," "seek, "will," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise, except as required by law.
View original content to download multimedia:http://www.prnewswire.com/news-releases/univar-solutions-and-novozymes-provide-biological-solutions-that-address-growing-health-consciousness-and-sustainability-demand-in-the-food-market-301276466.html
SOURCE Univar Solutions Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: UBS Starts Univar (UNVR) at Buy
- Targovax granted European Patent for ONCOS-102 in combination with chemotherapy
- Healthcare Trust Announces Series A Preferred Stock Dividend
Create E-mail Alert Related CategoriesPRNewswire, Press Releases
Related EntitiesIndustrial Production, Definitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!